Docetaxel and Bortezomib in Treating Patients With Progressive or Recurrent Non-Small Cell Lung Cancer
Clinical trial NCT00362882 · COMPLETED
Trial details
- NCT number
- NCT00362882
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-07-01
- Primary completion
- 2010-07-01
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.